摘要
目的：观察重组心钠肽治疗急性心力衰竭的疗效。方法：采用完全随机法将80例患者分为对照组和治疗组，对照组行硝酸甘油治疗，对照组行重组心钠肽治疗。观察两组患者的症状改善情况。结果：治疗组有效率为92.5%，对照组为67.5%，两组相比差异有统计学意义（p<0.05）。结论：重组心钠肽治疗急性心力衰竭疗效显著，值得临床推广使用。
Abstract
Objective: To observe the effect of recombinant atrial natriuretic peptide in the treatment of acute heart failure. Methods: a completely randomized 80 patients were randomly divided into control group and treatment group, the control group for nitroglycerin treatment, control group received recombinant atrial natriuretic peptide treatment. Two groups were observed in patients with symptoms to improve the situation. Results: the effective rate of the treatment group was 92.5%, 67.5% in the control group, there was significant difference between two groups (p<0.05). Conclusion: recombinant atrial natriuretic peptide significantly in treatment of acute heart failure curative effect, worthy of clinical use.
NETL
NSTL
万方数据